Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$32,383,812
in 18 filings, $13.4M under 10b5-1 plans

Net −$32,383,812. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$9.1M President and COO sold 48% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2026-03-06 RUBINSTEIN JULIE President and COO Option exercise · Stock Option (right to buy) 10b5-1 −11,881 415,820
2026-03-06 ROBINS HARLAN S Chief Scientific Officer Grant or award +709,220 1,992,324
2026-03-06 ROBINS CHAD M CEO and Chairman Grant or award +709,220 2,771,280
2026-03-05 LO FRANCIS Chief People Officer Sale −38,074 $15.09 $575K 321,967
2026-03-05 RUBINSTEIN JULIE President and COO Option exercise 10b5-1 +14,722 $6.55 $96K 594,295
2026-03-05 RUBINSTEIN JULIE President and COO Option exercise 10b5-1 +11,881 $12.14 $144K 606,176
2026-03-05 RUBINSTEIN JULIE President and COO Sale 10b5-1 −30,941 $16.00 $495K 575,235
2026-03-05 RUBINSTEIN JULIE President and COO Option exercise · Stock Option (right to buy) 10b5-1 −14,722 151,159
2026-03-05 RUBINSTEIN JULIE President and COO Option exercise · Stock Option (right to buy) 10b5-1 −11,881 427,701
2026-03-04 OWEN KATEY EINTERZ Director Grant or award +15,625 88,254
2026-03-04 BOBULSKY SUSAN Chief Commercial Officer, MRD Grant or award +59,375 406,613
2026-03-04 BOBULSKY SUSAN Chief Commercial Officer, MRD Grant or award +62,500 469,113
2026-03-04 BENZENO SHARON Chief Commercial Ofc Imm Med Grant or award +39,063 335,854
2026-03-04 ROBINS HARLAN S Chief Scientific Officer Grant or award +127,813 1,283,104
2026-03-04 RUBINSTEIN JULIE President and COO Grant or award +81,250 656,485
2026-03-04 PISKEL KYLE Chief Financial Officer Grant or award +61,875 278,512
2026-03-04 LO FRANCIS Chief People Officer Grant or award +44,063 360,041
2026-03-04 ROBINS CHAD M CEO and Chairman Grant or award +127,813 2,062,060
2026-03-04 HERSHBERG ROBERT Director Grant or award +15,625 62,347
2026-03-04 NEUPERT PETER M Director Grant or award +15,625 240,315

Page 19 of 119 · 2,375 trades